Researchers at the National University of Science and Technology MISIS have created a unique non-invasive nanosensor for measuring copper levels in...
Vous n'êtes pas connecté
A key driver in Brain Health growth is Quest Diagnostics' (DGX) Alzheimer's disease portfolio, featuring the AD-Detect blood testing services and the CSF Tests for diagnosing and monitoring.
Researchers at the National University of Science and Technology MISIS have created a unique non-invasive nanosensor for measuring copper levels in...
AI matches ophthalmologists in diagnosing corneal infections, offering accuracy and speed, a study finds, highlighting AI's potential in eye care...
GENEVA, Switzerland – As part of ongoing efforts to enhance quality-assured testing options, the World Health Organization (WHO) has listed two...
Middle-aged people with health risks such as uncontrolled blood pressure, blood sugar, and cholesterol, along with unhealthy habits like poor diet,...
HeraMED, Lumos Diagnostics and LTR Pharma are among ASX health companies reporting strong quarterly results this week. ...
Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A study published in...
Heather Snyder discusses the Alzheimer's Association's research initiatives, breakthroughs in diagnostics, and the importance of collaboration in...
The centralised disease hub will be tasked with “stress-testing” Australia’s ability to cope with future pandemics and other major health...
Results provide first evidence of biological and clinical effect of a mid-domain tau-targeting disease-modifying therapy1 In full study population...